• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BD Recalls Intraosseous Products Over Multiple Issues

    Rapid Medical Expands U.S. Portfolio

    MMS Holdings Partners With Lindsay Goldberg

    ENDRA Life Sciences Issued 28th Patent

    Levita Magnetics Closes $26M Series C
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Trademark Plastics Inc.

    Cirtec Medical

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Trademark Plastics Inc.

    Cirtec Medical

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Potential Sunshine Act Changes & A 2018 Midterm Elections Update

    ...

    Potential Sunshine Act Changes & A 2018 Midterm Elections Update
    Related CONTENT
    • The Tax Man Cometh for the Healthcare Industry—Again
    • Industry Applauds House Passage of Device Tax Repeal Bill
    • The State of Supply Chain Risk
    • Buyer (and Seller) Beware: Rate-Setting Commissions and the Future of Healthcare Delivery
    • Medical Devices and the Political Climate of 2018: An Update from the Swamp
    Jeffrey J. Kimbell and David C. Rudloff , Jeffrey J. Kimbell & Associates Inc.07.26.18
    Of particular interest to the life sciences industry are a series of recent efforts by the U.S. Congress to expand the scope of the Physician Payments Sunshine Act—a 2010 law that requires transactional transparency between drug and device manufacturers and their customers or providers.

    On June 12, the U.S. Senate Finance Committee voted unanimously to advance the Helping to End Addiction and Lessen Substance Use Disorders (HEAL) Act of 2018. The legislative package contains a measure that would expand Sunshine Act provisions by requiring drug and device manufacturers to publicly disclose the payments they make to nurse practitioners and physician assistants for promotional talks, consulting, and other interactions. The Sunshine Act already requires such transparency for payments made to physicians and academic medical centers.

    Some members of Congress have proposed going even further in expanding the law. Senator Claire McCaskill (D-MO) filed an amendment to the HEAL Act that would greatly expand the scope of the Sunshine Act. McCaskill’s original amendment would have required drug manufacturers to publicly disclose payments made to patient groups and advocacy organizations such as a professional society of healthcare providers or pharmacists; a patient or consumer advocacy organization; a patient education organization; a provider of continuing education; a clinical trial organization; an educational accreditation organization; and a co-pay assistance organization or any organization providing financial assistance to patients. However, during the Senate Finance Committee markup of the HEAL Act on June 12, Senator McCaskill offered, and later withdrew, a modified version of her original amendment. The modified amendment would have required only opioid manufacturers to publicly report payments made to patient groups and advocacy organizations, in the same manner in which they currently report payments to physicians and teaching hospitals under the Sunshine Act. After withdrawing her amendment, McCaskill stated that she is working with Senators Chuck Grassley (R-IA) and Bill Cassidy, M.D., (R-LA) on compromise modifications to her amendment that she is negotiating to be included in the final text of the bill on the Senate floor. In the markup, Senator Cassidy added there should be transparency in what pharmaceutical companies give to patient advocacy groups because of potential conflicts of interest. Senator Cassidy stated that he had received assurances from the Committee that this matter will be discussed in a separate future hearing on drug costs.

    In the same vein as Senator McCaskill’s modified amendment, on the House side, U.S. Rep. Jan Schakowsky (D-IL), a notable supporter of single-payer healthcare, introduced an amendment to H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. Like the McCaskill amendment, Schakowsky’s would expand Sunshine Act provisions to require opioid manufacturers to publicly disclose any payments made to patient groups and advocacy organizations. Schakowsky’s amendment was not included in the bill, but serves as a warning sign that members of Congress are considering changes to the Sunshine Act.

    While some of these proposals do not affect the medical device industry directly, it is important to monitor the increased scrutiny Congress is giving to the relationship between manufacturers and advocacy groups. Senator McCaskill and Rep. Schakowsky’s amendments would have created yards of unnecessary red tape and reporting requirements for manufacturers as well as making industry collaboration with stakeholders more difficult. As members of the life sciences community, it is important that we collaborate with groups representing the patients and physicians who use our products. These groups provide important advocacy bridges from the manufacturer to the public and help make our voices heard in an increasingly challenging regulatory environment. Judging by the recent activity with this issue, we will continue to see more criticism of these relationships, especially if Congress changes hands next year.

    2018 Midterm Elections Update
    Much has happened on the campaign trail since our previous update. Over half of the states have held their primary elections, allowing us to get a better glimpse of what the races will look like in November. On May 8, businessman Mike Braun won a heated Republican primary for the Senate race in Indiana. By pegging himself as a true Washington outsider, Braun was able to defeat two sitting U.S. Congressmen, Reps. Luke Messer (R-IN) and Todd Rokita (R-IN) with 41 percent of the total vote. Braun now faces incumbent U.S. Senator Joe Donnelly (D-IN) in a state where President Trump won by 19 percentage points. We expect this race to be competitive, but give Braun the edge given the popularity of the President in ruby-red Indiana.

    In North Dakota, incumbent Senator Heidi Heitkamp (D-ND) faces U.S. Rep. Kevin Cramer (R-ND) in what is seen as one of the bigger pick-up opportunities for Republicans. Heitkamp has voted as a moderate, but it will be hard for her to distance herself from her party in this polarized climate when Trump won North Dakota by over 35 points in 2016. The President has been active on the campaign trail and hosted a large rally in Fargo on June 27 to support Cramer.

    Another competitive race ensues in West Virginia, where incumbent Senator Joe Manchin (D-WV) will take on Republican challenger Patrick Morrissey. Morrissey, the current Attorney General of West Virginia, won a heated three-way primary defeating sitting U.S. Rep. Evan Jenkins (R-WV) and coal baron Don Blankenship in the process. Trump won West Virginia by 42 percentage points, the largest margin of victory for any presidential election in the state’s history; however, Manchin remains popular as a moderate “blue dog” Democrat. This race will be competitive but, perhaps seeing the writing on the wall, Manchin recently stated that he regrets voting for Hillary Clinton and would be open in 2020 to supporting Trump.

    Montana poses another potential blue-to-red pickup for the GOP. On June 5, Montana State Auditor Matt Rosendale won a contested four-way Republican primary to take on sitting Senator Jon Tester (D-MT). Montana is another red state that Trump won by a large margin, but unlike some of his moderate Democratic cohorts, the former rancher Tester has bona fide blue-collar credentials. It is important to note, however, that Tester has never won a race with over 50 percent of the vote. We expect this race to be decided by less than 20,000 votes.

    For Democrats, their biggest opportunity to steal a red Senate seat will be Nevada, where incumbent U.S. Senator Dean Heller (R-NV) will face Congresswoman Jacky Rosen (D-NV) in the November Senate election. Nevada is a purple state, but has been trending blue in recent elections. Barack Obama won Nevada in 2008 and 2012, and in 2016 Hillary Clinton won the state by over two percentage points. In the 2012 Senate race, Heller won by a razor thin margin of just 10,000 votes. The challenger Rosen will also be sure to take advantage of the fact that President Trump has a net disapproval rating of negative two in Nevada. Democrats certainly see Nevada as one of their best pickup opportunities and this race will be decided by less than 25,000 votes.

    On the House side, the generic ballot lead for the Democrats has evaporated to just three percentage points, which is within the margin of error. According to the latest June 22 Gallup poll, so has the so-called “enthusiasm gap.” Voter enthusiasm previously favored heavily toward the Democrats, but now the percentage of Democrats and Republicans who are “absolutely certain to vote” in 2018 has evened to around 65 percent for both parties. The party out of power usually has more motivation going into midterm elections, but these recent poll numbers reflect the painstakingly hyper-partisan nature of the current political climate.

    These midterms are especially difficult to predict because analyses by different electoral indicators point to swings in the opposite direction. The economy, by all indications, is doing extraordinary well so far under Trump’s presidency. As expected, the party in power typically gets credit during good economic conditions, which would bode well for the Republicans. Fittingly so, according to FiveThirtyEight’s analysis, if you forecasted the 2018 midterms based on the public’s view of the economy, the GOP would actually gain 55 seats. However other indicators, such as presidential approval, are not favorable for the GOP. President Trump’s approval rating sits around 43 percent which, if forecasted according to FiveThirtyEight’s methodology, would cause the Republicans to lose 68 seats in the elections.

    A third set of indicators are the results of recent special elections. Democrats have over performed by an average of nine points in every federal special election since President Trump took office. A nine-point swing for Democrats would put the 2018 elections on par with the “wave” elections of 1994 and 2010, but the current generic ballot suggests Democrats should not be as optimistic. Of course, you cannot predict elections based on one set of factors since voters have different and, sometimes, contradictory reasons for voting, but these indicators will be especially interesting to watch looking toward November. Democrats need to flip 23 seats to take back the House and Las Vegas has their odds set at 50/50. Today, we anticipate the GOP losing between 12 to 16 seats in the House and picking up a net of plus two seats in the Senate. 


    Jeffrey J. Kimbell, president and founder of Jeffrey J. Kimbell & Associates Inc., represents over 35 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the firm provides strategic solutions to hand-selected clients seeking creation, modification, or proper implementation of public law.

    David C. Rudloff is a manager of government relations at Jeffrey J. Kimbell & Associates Inc. He previously worked as a litigation paralegal at Covington & Burling in Washington, DC. David graduated from Davidson College in 2016 with a B.A. in political science. 
    Related Searches
    • trump
    • pharmaceutical
    • manufacturer
    • medical
    Suggested For You
    The Tax Man Cometh for the Healthcare Industry—Again The Tax Man Cometh for the Healthcare Industry—Again
    Industry Applauds House Passage of Device Tax Repeal Bill Industry Applauds House Passage of Device Tax Repeal Bill
    The State of Supply Chain Risk The State of Supply Chain Risk
    Buyer (and Seller) Beware:  Rate-Setting Commissions and the Future of Healthcare Delivery Buyer (and Seller) Beware: Rate-Setting Commissions and the Future of Healthcare Delivery
    Medical Devices and the Political Climate of 2018: An Update from the Swamp Medical Devices and the Political Climate of 2018: An Update from the Swamp
    Manufacturing’s Great Opportunity Manufacturing’s Great Opportunity
    Cook Group Promotes Executive to Federal and International Government Affairs VP Cook Group Promotes Executive to Federal and International Government Affairs VP
    MedTech M&A and Manufacturing Predictions for 2018 MedTech M&A and Manufacturing Predictions for 2018

    Related Columns

    • The Tax Man Cometh for the Healthcare Industry—Again

      The Tax Man Cometh for the Healthcare Industry—Again

      ...
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Next Life Medical CEO, Emergent Respiratory 07.26.18

    • Industry Applauds House Passage of Device Tax Repeal Bill

      Industry Applauds House Passage of Device Tax Repeal Bill

      Moves onto the Senate for consideration.
      Sean Fenske, Editor-in-Chief 07.25.18

    • The State of Supply Chain Risk

      The State of Supply Chain Risk

      ...
      James A. Dunning, Principal, QPC Services LLC 06.04.18


    • Buyer (and Seller) Beware:  Rate-Setting Commissions and the Future of Healthcare Delivery

      Buyer (and Seller) Beware: Rate-Setting Commissions and the Future of Healthcare Delivery

      ...
      Jeffrey J. Kimbell and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 06.04.18

    • Medical Devices and the Political Climate of 2018: An Update from the Swamp

      Medical Devices and the Political Climate of 2018: An Update from the Swamp

      ...
      Jeffrey J. Kimbell and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 05.03.18

    Loading, Please Wait..

    Trending
    • Cardinal Health CEO Mike Kaufmann Steps Down
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • TruArc Expands Medical Portfolio With Acquisition Of Molded Devices Inc.
    • Chronic, Infectious Disease Prevalence To Benefit Vital Signs Monitoring Market
    Breaking News
    • BD Recalls Intraosseous Products Over Multiple Issues
    • Rapid Medical Expands U.S. Portfolio
    • MMS Holdings Partners With Lindsay Goldberg
    • ENDRA Life Sciences Issued 28th Patent
    • Levita Magnetics Closes $26M Series C
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    Valspar Reveals Fresh Lineup of New Shades in 2023 Colors of the Year
    Evonik Grows Strongly in 1H 2022
    PPG Chairman and CEO Joins Disability:IN Effort to Advance Disability Inclusion
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BD Recalls Intraosseous Products Over Multiple Issues
    Rapid Medical Expands U.S. Portfolio
    MMS Holdings Partners With Lindsay Goldberg
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Invests $65M to Expand North American HQ
    Pace Appoints Nisheet Gupta as EVP and Chief Financial Officer
    West Pharmaceutical Makes Strategic Investment in Latch Medical
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Murad Unveils Supplement Product Lineup to Combat Acne, Aging
    R+Co Launches New Hairstyling Products
    Clinique Launches Pop Plush Creamy Gloss in its Iconic Black Honey Hue
    Ink World

    Latest Breaking News From Ink World

    Evonik Enjoys 31% Growth in 1H 2022
    Sun Chemical Returns to Labelexpo Americas 2022
    DIC Reports Consolidated Financial Results 1H 2022
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Colordyne hosts open house featuring hybrid print technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business
    Stratasys Signs Agreement to Acquire Covestro’s Additive Manufacturing Materials Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login